mild-, moderate-and severe-persistent patients: 3.2% vs 3.0%, 11.5% vs 9.7%, 21.2% vs 19.9%, and 64.1% vs 67.4%, respectively. When LTRA was added to ICS/LABA, control levels were similar using GINA 2012 and lower using GINA 2018 criteria. The proportion of patients with intermittent, mild-, moderate-and severe-persistent asthma controlled at Week 12 (GINA 2012) as one of the poor prognostic factors in asthma. Little is known about the association between the small airway dysfunction and fixed airflow obstruction in aged asthma population.
80.0%, 86.5% vs 85.8%, 78.5% vs 71.3%, and 59.6% vs 61.8%, respectively. Using GINA 2018 criteria, the proportion was 86.8% vs 95.9%, 86.1% vs 93.2%, 82.1% vs 85.3%, and 71.9% vs 77.6%, respectively.
Conclusion:
In this Chinese non-interventional study, irrespective of the GINA criteria used and baseline severity, adding LTRA to ICS/LABA did not improve the level of asthma control and may have been unnecessary in some of these newly diagnosed patients. Methods: Asthma patients 1) over the age of 40 years or more with a 2) diagnosis of asthma based on either positive bronchodilator test or provocation test and 3) post-bronchodilator (BDR) FEV1/FVC ratio < 70 were enrolled. FAO was defined as post-BDR FEV1/FVC ratio <70 in at least 3 months follow up tests. Small airway dysfunction was assessed by RV/TLC ratio done at the initial examination. Retrospective chart review was done.
Results: Total 140 patients were included, 77 (55%) had FAO in subsequent PFT. 45 % were male, mean age was 60.2 (41-80). 26.7% were ever smokers and mean smoking history was 30.5 (3-90) packyears. 25.7% had atopy, mean serum IgE was 205 (4-1000) and peripheral eosinophil counts were 411 (0-1651). The mean pre-BDR FEV1/FVC ratio was 57.3 (31-70), FEV1 (%) was 66.9% (28-110). Initial RV (%) was 108 (44-247) and RV/TLC (%) was 38 (21-74). Follow up PFT were done after mean 28 AE 22.6 months. In univariate analysis, male, old age, high smoking pack-years, low pre-FEV1/FVC ratio, high RV/TLC (41.4 AE 11.6 vs 34.3 AE 8.3, P = 0.005), high serum IgE were associated with the risk of FAO. Positive provocation test and bronchodilator responses were negatively correlated with the FAO.
The risk of FAO in asthma patients with airflow obstruction at initial evaluation was higher in patients who had air trapping by small airway dysfunction, assessed by high RV/TLC ratio. Although further prospective studies would be needed with long term observation periods, this study implies the positive correlation between the initial small airway dysfunction and progressive airflow limitation in aged asthma patients. Background and Aims: Chitin, a polymer made up of repeating units of β-(1-4)-poly-N-acetyl-d-glucosamine, is a ubiquitous polysaccharide found in the walls of fungi and the exoskeleton of arthropods such as crabs, shrimp, and insects. As it does not have a mammalian counterpart, chitin could be important inhalant antigen for bronchial asthma. Chitin stimulates innate immune cells and regulates adaptive allergic immune responses. Previous studies have shown that as pathogen-associated patterns induced prostaglandin E 2 (PGE 2 ) production was independent of the NLRP3 inflammasome. In this study, we investigated whether chitin induces the PGE 2 production in alveolar macrophages and bronchial epithelial cells.
Methods: Mice were intranasally injected chitin on consecutive 3 days, and after 24 h from last injection bronchoalveolar lavage (BAL) fluids were collected. After alveolar macrophage preparation, total cellular RNA was isolated from alveolar macrophages and the supernates of the alveolar macrophage cultures were collected. The expression mRNA levels of PGE 2 synthases in mouse alveolar macrophages, MH-S cells (mouse alveolar macrophages cell line), and BEAS-2B cells (human bronchial epithelial cell line) after treatment with chitin were evaluated by quantitative real-time reverse transcription-PCR.
Results: The murine model of chitin-induced airway inflammation showed the inflammatory cell infiltration into BAL fluids and higher concentrations of PGE 2 in BAL fluids, as compared to control mice. Levels of cyclooxygenase (COX) 2 and microsomal PGE2 synthase (mPGES)-2 mRNA expression and PGE 2 in culture supernatants of alveolar macrophages were significantly increased after the treatment with chitin. Moreover, we also showed that chitin induced mRNA expression levels of PGE 2 synthases in MH-S cells and BEAS-2B cells.
These results suggested that chitin has the potential to induce airway inflammation and PGE 2 production in alveolar macrophages and bronchial epithelial cells. Background and Aims: Chronic inflammation in asthma will cause healing processes and inflammation that may cause structural changes in the airways (remodelling). Tissue remodelling would cause severe airway limitation and worsen asthma. Plasminogen activator inhibitor-1 (PAI-1) considered to play an important role in the process of fibrosis after inflammation. The objectives of the study to assess the correlation between levels of PAI-1 and severity of asthma and lung function
